Legal & General Group Plc Reduces Stock Holdings in Healthpeak Properties, Inc. $DOC

Legal & General Group Plc lowered its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 18.1% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 5,428,632 shares of the real estate investment trust’s stock after selling 1,197,609 shares during the quarter. Legal & General Group Plc owned 0.79% of Healthpeak Properties worth $116,173,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of DOC. Norges Bank bought a new stake in Healthpeak Properties in the fourth quarter worth $153,550,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in Healthpeak Properties by 694.6% during the third quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust’s stock valued at $153,520,000 after acquiring an additional 7,007,777 shares during the last quarter. Bank of New York Mellon Corp raised its stake in shares of Healthpeak Properties by 60.3% in the first quarter. Bank of New York Mellon Corp now owns 15,456,420 shares of the real estate investment trust’s stock valued at $253,949,000 after acquiring an additional 5,815,189 shares during the period. Fuller & Thaler Asset Management Inc. raised its stake in shares of Healthpeak Properties by 19.2% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock valued at $476,744,000 after acquiring an additional 4,776,056 shares during the period. Finally, Massachusetts Financial Services Co. MA lifted its holdings in shares of Healthpeak Properties by 214.0% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 4,230,551 shares of the real estate investment trust’s stock worth $98,050,000 after acquiring an additional 2,883,382 shares during the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Stock Performance

DOC stock opened at $21.23 on Friday. Healthpeak Properties, Inc. has a twelve month low of $15.70 and a twelve month high of $22.95. The firm has a market cap of $14.64 billion, a price-to-earnings ratio of 60.67, a PEG ratio of 2.35 and a beta of 1.01. The business’s fifty day simple moving average is $21.52 and its two-hundred day simple moving average is $19.17. The company has a quick ratio of 3.02, a current ratio of 3.02 and a debt-to-equity ratio of 1.06.

Healthpeak Properties (NYSE:DOC) last issued its earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.03 by $0.05. The firm had revenue of $771.58 million during the quarter, compared to analyst estimates of $725.64 million. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The business’s revenue was up 11.1% on a year-over-year basis. During the same period in the previous year, the firm earned $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. Analysts predict that Healthpeak Properties, Inc. will post 1.77 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The business also recently disclosed a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be issued a dividend of $0.1017 per share. The ex-dividend date is Monday, September 14th. This represents a c) dividend on an annualized basis and a yield of 5.7%. Healthpeak Properties’s dividend payout ratio (DPR) is presently 348.57%.

Analysts Set New Price Targets

DOC has been the subject of a number of recent analyst reports. Barclays began coverage on shares of Healthpeak Properties in a research note on Tuesday, July 7th. They set an “equal weight” rating and a $23.00 price target for the company. BMO Capital Markets increased their price objective on shares of Healthpeak Properties from $20.00 to $24.00 and gave the stock an “outperform” rating in a research report on Monday, June 15th. Mizuho raised their price objective on shares of Healthpeak Properties from $21.00 to $24.00 and gave the stock an “outperform” rating in a research note on Monday, July 6th. Raymond James Financial started coverage on Healthpeak Properties in a research report on Wednesday, June 17th. They set a “market perform” rating for the company. Finally, Cantor Fitzgerald boosted their target price on Healthpeak Properties from $20.00 to $23.00 and gave the company a “neutral” rating in a research report on Thursday, August 6th. Four research analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $21.66.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.